baber/WOPTO huggingface dataset:
Patent CA-2972624-A1 (CA)
Inventor: VAN MILL MICHAEL D
IPC: B65G67/24
Filed: 2017-06-30
Abstract: A cart for transporting and conveying agricultural materials is provided. The cart includes a frame; a set of wheels or tracks coupled with said frame; and a hitch assembly coupled with said frame to allow the cart to be towed on the wheels or tracks behind a tow vehicle. The cart further includes a hopper defined by a plurality of walls supported by the frame and having a hopper opening to receive agricultural material and a discharge opening for discharging agricultural material. The cart further includes a conveyor assembly coupled to the hopper, the conveyor assembly including an inlet in communication with the discharge opening to receive agricultural material therefrom and an outlet to discharge agricultural material. The conveyor assembly includes a lower conveyor section and an upper conveyor section. The lower conveyor section includes a lower conveyor housing and a lower conveyor extending within the lower conveyor housing and the upper conveyor section including an upper conveyor housing and an upper conveyor extending within the upper conveyor housing. The upper conveyor section is pivotable about a second tilt axis located between said lower and upper conveyor sections and positioned at an acute angle from vertical.
Patent CA-2973821-A1 (CA)
Title: Electrical switching apparatus with terminal guard assembly
Inventor: CROOKS WILLIAM M
IPC: H01H9/02
Filed: 2016-01-08
Abstract: A guard assembly (100,300,500) is for an electrical switching apparatus (4,204,404) of an electrical system (2,202,402). The electrical system (2,202,402) includes a number of conductors (6,206,406) each having an insulated portion (8) and an exposed portion (10) that meet at a junction (12). The electrical switching apparatus (4,204,404) includes a housing (18,218,418) and a number of terminals (14) connected to the exposed portion (10) of a conductor (6,206,406). The guard assembly (100,300,500) comprises: an interconnect member (110,310,550) coupled to the housing (18,218,418); and a number of guard members (130,330,530) each comprising: a first portion (132,332) coupled to the interconnect member (110,310,550), and a second portion (134,334) extending from the first portion (132,332) away from the housing (18,218,418), the second portion (134,334) comprising: a first distal end (136,342) located at the first portion (132,332), and a second distal end (138,344) opposite and distal from the first distal end (136,342). Each of the guard members (130,330,530) has an opening (139). The opening (139) receives a conductor (6,206,406). Each junction (12) is located between a second distal end (138,344) and a terminal (14).
Patent CA-2976221-A1 (CA)
Inventor: KOVACS DAVID H
IPC: A61M5/31
Filed: 2017-08-11
Abstract: An automatic retractable syringe comprised of a syringe inside a compressed spring loaded locking safety sheath that moves into a protective position over the needle of the syringe utilizing a positional locking mechanism on the side of said safety sheath that in the open/ready, or needle exposed position, retains said safety sheath with the needle of said syringe exposed for use, where the plunger does not trigger said locking mechanism when drawn outward from the barrel and when said plunger is depressed, the bottom of the plunger top depresses the mechanism trigger, closing the gap at position A and forcing said locking mechanism out of said position A causing said locking mechanism to be under tension while displaced and the spring to expand and the locking safety sheath to move into its protective position, where a portion of said locking safety sheath covers the needle, causing said locking mechanism to move to position B, where said locking mechanism then locks in place in position B, preventing said locking safety sheath from further movement, said position B comprises an optional fusing system, said fusing system is comprised of an adhesive or bonding chemical contained in a protective but breakable coating, said locking mechanism is protected by a tamperproof encasement, said needle is covered by a removable needle cap prior to use, said locking safety sheath is also comprised of a viewing port, a safety tab, stoppers, and stabilizer guides.
Patent CA-2977309-A1 (CA)
Inventor: DE NAEYER AN
IPC: A61M5/24
Filed: 2016-02-25
Abstract: The present Invention relates to a kit for applying a liquid composition on or in the skin, comprising an injection device and one or more cartridges, provided with a container appropriate for receiving a liquid composition, in which the injection device is provided with means for receiving a cartridges, characterized in that the container is provided with a movable body. The cartridge is provided with a peripheral edge, that allows the safe removal of a used cartridge out of the device, In a second aspect, the invention relates to a method for applying a liquid composition onto the skin.
Patent CA-2977659-A1 (CA)
Inventor: QIAO LEI
IPC: C07D487/04
Filed: 2016-02-26
Abstract: The present application provides processes for preparing (R)-4-(3-((S)-1-(4-amino-3-methyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)pyrrolidin-2-one, which is useful as an inhibitor phosphoinositide 3-kinase-delta (PI3Kd), as well as a salt form and intermediates related thereto.
Patent CA-2978526-A1 (CA)
Inventor: DRANITZKI-ELHALEL MICHAL
IPC: C07K14/525
Filed: 2016-03-03
Abstract: The invention provides a composition and use of a composition comprising a fusion protein and a first ligand in a ratio sufficient to increase therapeutic efficacy of the fusion protein in a subject, the fusion protein comprising an extracellular domain (ECD) of a first receptor and a second ligand, wherein the second ligand is capable of binding to a second receptor, wherein the first ligand is capable of binding to the first receptor, wherein the first and second ligands, and the first and second receptors, are TNF-family members, and wherein the first and second ligands are different, and the first and second receptors are different. The invention also provides a composition comprising Fn14-TRAIL fusion protein and TWEAK and use thereof for treating diseases or conditions associated with increased levels of TWEAK. The invention is further directed to use of Fn14-TRAIL fusion protein to treat diseases or conditions associated with increased levels of TWEAK.
Patent CA-2980730-A1 (CA)
Title: Nanoparticules tolerogeniques pour le traitement du diabete sucre
Inventor: BORNAL ADA YESTE
IPC: A61K47/69
Filed: 2016-03-23
Abstract: L'invention concerne des méthodes et des compositions permettant d'augmenter le nombre et/ou l'activité des cellules T régulatrices (Tregs) in vivo et in vitro, afin d'induire une tolérance à des auto-antigènes diabétogènes.
Patent CA-2981652-A1 (CA)
Title: Freeform nanostructured surface for virtual and augmented reality near eye display
Inventor: ROLLAND JANNICK
IPC: G02B5/18
Filed: 2016-03-31
Abstract: A near eye display includes at least one of a combiner, a secondary mirror, and a waveguide having a freeform nanostructured surface. The freeform nanostructured surface encompasses a freeform surface, a nanostructured surface or a combination of both the freeform surface and the nanostructured surface. The freeform nanostructured surface can be incorporated into a combiner or a secondary mirror in the near eye display in a compact folded geometry, wherein an anamorphic or freeform optic can be optically intermediate an image source and the freeform nanostructured surface. The nanostructured surface can include a meta-grating operable across the visible spectrum. The meta-grating includes meta-atoms configured to provide a given efficiency at the desired wavelengths in reflection.
Patent CA-2985071-A1 (CA)
Inventor: HRISCU IOSIF
IPC: E21B43/24
Filed: 2016-06-06
Abstract: A system and method for underground gasification. A system for underground gasification system may comprise a recovery system, a supply line, and a downhole ignition device operable to ignite an underground energy source. The downhole device may be connected to the supply line and the supply line may be connected to the recovery system. The system for underground gasification may further comprise an information handling system that may be operable to control the downhole device. A method for igniting an underground energy source may comprise disposing a downhole ignition device into an injection well, positioning the downhole ignition device within the underground energy source, activating the downhole ignition device, igniting the underground energy source, and recovering a gas from the underground energy source.
Patent CA-2985219-A1 (CA)
Inventor: YANG SHIBAO
IPC: A61K31/4152
Filed: 2016-06-08
Abstract: The present invention relates to the use of a composition for preparing a medicament for the treatment of amyotrophic lateral sclerosis and associated disorders. The composition comprises 3-methyl-1-phenyl-2-pyrazoline-5-one or pharmaceutically acceptable salts thereof and borneol. The medicament is a drug used for delaying the occurrence time of amyotrophic lateral sclerosis and extending the survival time, and for improving memory function defect of amyotrophic lateral sclerosis.
Patent CA-2989740-A1 (CA)
Title: Stimulators and/or activators of soluble guanylate cyclase (sgc) in combination with an inhibitor of neutral endopeptidase (nep inhibitor) and/or an angiotensin aii antagonist and the use thereof
Inventor: MARQUARDT TOBIAS
IPC: A61K45/06
Filed: 2016-07-15
Abstract: The present invention relates to stimulators and activators of soluble guanylate cyclase in combination with an inhibitor of neutral endopeptidase and/or angiotensin AII antagonist and the use thereof for treatment and/or prophylaxis of cardiovascular disorders, for example heart failure with maintained ejection fraction or heart failure with reduced ejection fraction, renal disorders, for example chronic kidney failure, urological disorders, pulmonary disorders, disorders of the central nervous system, for regulation of cerebral perfusion, for example in the event of vascular cerebral states of dementia, for treatment and/or prophylaxis of fibrotic disorders and other disease symptoms (for example end organ damage affecting the brain, kidney or heart).
Patent CA-2993634-A1 (CA)
Title: Application d'amides de 7-carboxybenzo[1,2,3]thiadiazole comme stimulants de plantes
Inventor: SMIGLAK MARCIN
IPC: A01P15/00
Filed: 2016-07-27
Abstract: L'invention concerne des amides de 7-carboxybenzo[1,2,3]thiadiazole et des dérivés de celles-ci ayant une forme générale (I), telle que décrite dans l'invention. L'invention concerne aussi des combinaisons et des compositions de ces composés. Les composés et compositions peuvent être utilisés comme stimulants de plantes. Par exemple, les compositions de composés peuvent être utilisées pour réguler la croissance des plantes, réguler les processus métaboliques des plantes, réguler les processus physiologiques des plantes, protéger contre les effets de stress biotiques dans les plantes, ou protéger contre les effets de stress abiotiques dans les plantes. Dans certains modes de réalisation, la composition peut offrir une résistance à de multiples maladies aux plantes infectées par un fongus, un virus ou une bactérie.
Patent CA-2995434-A1 (CA)
Title: Method for autoclave-free lamination of a composite pane
Inventor: GIER STEPHAN
IPC: B32B17/10
Filed: 2016-12-12
Abstract: The present invention relates to a method for autoclave-free lamination of a composite pane, wherein: (a) a stack sequence of a substrate pane, at least one intermediate layer, and a cover pane is produced, (b1) a vacuum ring or a vacuum bag is placed around the stack sequence, (b2) the stack sequence is deaerated for a period of t >= 8 min and at a temperature T from 0 °C to 30 °C by application of a negative pressure of p <= 0.3 bar to the vacuum ring or the vacuum bag, (b3) the stack sequence is heated to a temperature T of 70 °C to 115 °C, (b4) the stack sequence is deaerated for a period t of t >= 8 min by application of a negative pressure of p <= 0.3 bar to the vacuum ring or the vacuum bag, (b5) the stack sequence is cooled to a temperature T < 70 °C, (b6) the vacuum ring or the vacuum bag is aerated which leads to a temperature of less than 40 °C, and is removed, (c1) the stack sequence is heated to a temperature T from 40 °C to 120 °C, and (c2) the stack sequence is pressed together between at least two opposing calender rollers of a first calender unit over the entire width b of the stack sequence.
Patent CA-2998023-A1 (CA)
Inventor: AMBROSE JAMES ALLEN
IPC: B60W40/09
Filed: 2018-03-13
Abstract: A driver logging device events generator. In example, the events generator includes an input port configured to receive telemetric data generated by a vehicle control module and sent from a vehicle diagnostic port; a positioning information source; and an electronic processor coupled to the input port and the positioning information source. The electronic processor is configured to receive telemetric data, location information, and timing data; process the telemetric data to extract a subset of data points; receive driver input from a mobile device; determine at least one event value based on the driver input, the location information, and the timing data; generate a logging device event from a pre-determined set of events based on the at least one event value, the event including an event type and an event code based on the driver input and the subset of data points; and send the event to the mobile device.
Patent CA-2999352-A1 (CA)
Inventor: SIX MARC-FRANCOIS
IPC: B06B1/04
Filed: 2018-03-23
Abstract: L'invention concerne un générateur (100) d'efforts dynamiques comportant : - un axe de support (110) ; - un premier rotor (120) comprenant : un alésage interne (121) logeant ledit axe (110) et des roulements (R1, R2) de sorte que le premier rotor (120) est monté à rotation par rapport à l'axe, un alésage externe (122) muni d'un premier ensemble (180) d'aimants permanents, une zone de connexion (123) entre les alésages interne et externe du premier rotor, ladite zone de connexion étant destinée à loger un bobinage apte à coopérer avec le premier ensemble d'aimants permanents pour constituer un moteur du premier rotor, - un premier balourd (130) fixé à l'alésage interne du premier rotor et monté en vis-à-vis de l'alésage externe du premier rotor ; - un deuxième rotor (140) monté à rotation par rapport au premier rotor, par l'intermédiaire d'un composant antifriction (160) et comprenant : un alésage interne (141) logeant l'alésage interne du premier rotor (120) de sorte que lesdits alésages internes sont concentriques, un alésage externe (142) muni d'un deuxième ensemble (181) d'aimants permanents, une zone de connexion (143) entre les alésages interne et externe du deuxième rotor, ladite zone de connexion étant destinée à loger un bobinage apte à coopérer avec le deuxième ensemble d'aimants permanents pour constituer un moteur pour le deuxième rotor; et - un deuxième balourd (150) fixé à l'alésage interne du deuxième rotor et monté en vis-à-vis de l'alésage externe du deuxième rotor.
Patent CA-2999553-A1 (CA)
Title: Improved use of silicon dioxide for improved health
Inventor: CALLUPE SUSAN
IPC: A61P7/08
Filed: 2018-03-28
Abstract: There is described the use of silica from 1% to 100 % by oral intake of Geothermal Amorphous 100 % natural Silica or any other types of silica SiO2 to improve, and change, the pH for humans and animals. Silica can be used to protect against cancer and to improve and help improve from cancer oral intake from 1% to 100%. Silica helps expel metals from the body. Silica as a cream can remove stretch marks on the skin. Silicon dioxide from 1% to 100% in solution can be used against candida and candida overgrowth, increase hair growth and prevent hair loss; and in a spray solution can be used to get rid of bed bugs.
Patent CA-3001467-A1 (CA)
Title: Stabilisation de compositions pharmaceutiques de camptothecine
Inventor: DRUMMOND DARYL C
IPC: A61K31/4745
Filed: 2016-10-15
Abstract: L'invention concerne des liposomes phospholipidiques d'irinotécan présentant une meilleure stabilité de stockage, ainsi que des méthodes associées de traitement et de fabrication. Les liposomes d'irinotécan peuvent présenter une formation réduite de lyso-phosphatidylcholine (lyso-PC) au cours du stockage, et avant l'administration à un patient.
Patent CA-3004000-A1 (CA)
Inventor: WATFORD RUSSELL THOMAS
IPC: H01H3/02
Filed: 2018-05-04
Abstract: A lockout subassembly of an electronic circuit breaker. The lockout subassembly includes a rotatable latch bar having an engagement portion configured to engage with and prevent movement of an operating handle to an ON position, the rotatable latch bar including a lock portion, and a latch device configured to be receivable in the lock portion, wherein rotation of the rotatable latch bar is limited between a first and second rotational position in response to the latch device being received in the lock portion. The lockout of the operating handle can be removed upon passing at least one test so that the operating handle can be moved to the ON position. Circuit breakers including the lockout subassembly and methods of operating the circuit breaker are provided, as are other aspects.
Patent CA-3008359-A1 (CA)
Inventor: BILODEAU MAGELLA
IPC: B02C13/18
Filed: 2018-06-15
Abstract: Disclosed is an apparatus that is an attrition mill for grinding or comminuting ores, mine wastes, and radioactive wastes some of which may comprise metals, which may include uranium and/or cesium and/or mercury and/or thorium and/or rare earth elements. Also disclosed are processes that employ the apparatus for combined grinding and optionally leaching metals from ores and wastes. Some such methods comprise an optional step of grinding and mixing the ore or waste with a solid inorganic base with water addition or with an aqueous inorganic base, follow by a step of grinding and mixing the ore or waste with an aqueous inorganic acid with or without leaching salt addition, to solubilize the metals present in the ore or the waste. The disclosed apparatus and methods, in some embodiments, enable efficient grinding and attrition of ores substrates and mine wastes even without need for grinding media.
Patent CA-3008706-A1 (CA)
Title: Metal oxides and/or hydrates thereof for stabilising an aqueous preparation against microbial growth
Inventor: URWYLER SIMON
IPC: A01P1/00
Filed: 2016-12-20
Abstract: The invention relates to a process for stabilising an aqueous preparation against microbial growth, the aqueous preparation stabilised against microbial growth as well as the use of a source of at least one metal oxide and/or its hydrated form for reducing the amount of an antimicrobial agent against at least one strain of bacteria and/or at least one strain of yeast and/or at least one strain of mould in an aqueous preparation, the use of a composition comprising at least one antimicrobial agent and a source of at least one metal oxide and/or its hydrated form as an antimicrobial composition in an aqueous preparation, the use of magnesium oxide, magnesium hydroxide, calcium oxide, calcium hydroxide, half burnt dolomite, burnt dolomite, beryllium oxide, beryllium hydroxide, strontium oxide, strontium hydroxide, barium oxide, barium hydroxide, and mixtures thereof for increasing the pH of an aqueous preparation to a pH of above 8 and the use of an aqueous preparation stabilised against microbial growth in paper, plastics, polymer compositions, paint, coatings, concrete and/or agriculture applications.
Patent CA-3008920-A1 (CA)
Inventor: HANSEN JOHN BONDO
IPC: A61P11/00
Filed: 2016-11-16
Abstract: L'invention concerne une composition comprenant du tosilate de suplatast ou des dérivés de qualité pharmaceutique de celui-ci pour utilisation dans une méthode de traitement de la toux associée à une maladie pulmonaire interstitielle, telle que la toux associée à la fibrose pulmonaire.
Patent CA-3013247-A1 (CA)
Inventor: SALANT DAVID J
IPC: A61K35/14
Filed: 2009-07-20
Abstract: The invention relates to immunoassays, reagents, therapeutics and methods of diagnosing and prognosis evaluation of idiopathic membranous nephropathy (MN). Immunoassays comprise enzyme-linked immunoabsorbent assays and nephelometric immunoassays for serum auto-antibodies reactive against a phospholipase A2 receptor (PLA2R). Therapeutic methods include removal of the auto-antibodies by adsorbance or administration of soluble PLA2R or fragments to sequester the auto-antibodies.
Patent CA-3013497-A1 (CA)
Inventor: YU CHONGXI
IPC: A61K47/54
Filed: 2009-12-04
Abstract: High penetration compositions (HPC) of a parent compound, which are capable of crossing biological barriers with high penetration efficiency. The HPCs are capable of being converted to parent drugs or parent drug-related compounds such as metabolites after crossing one or more biological barriers and thus can render treatments for the conditions that the parent drugs or parent drug-related compounds can. Additionally, the HPCs are capable of reaching areas that their parent drugs or parent drug-related compounds may not be able to access or to render a sufficient concentration at the target areas HPCs of NSAIA, for example, have demonstrated indications such as treating hair loss. A HPC can be administered to a subject through various administration routes, e.g., locally delivered to an action site of a condition with a high concentration or systematically administered to a biological subject and enter the general circulation with a faster rate.
Patent CA-3013929-A1 (CA)
Title: Contenants de refroidissement et d'hydratation et procedes d'utilisation associes
Inventor: LI JUSTIN B
IPC: A61F7/00
Filed: 2017-02-10
Abstract: La présente invention concerne des vessies/contenants conçus pour contenir une quantité significative de matériau (dans un état quelconque : solide, liquide ou gazeux) pour absorber par conduction la chaleur du corps humain. De plus, le matériau peut être consommé par l'utilisateur qui porte la vessie/le contenant, fournissant ainsi une source d'hydratation pour l'utilisateur. Les vessies/contenants peuvent également améliorer l'impact et/ou la protection balistique de l'utilisateur.
Patent CA-3015199-A1 (CA)
Inventor: GAILLARD LIONEL
IPC: G06Q10/10
Filed: 2018-08-23
Abstract: A method and system for updating contact details of users is disclosed. The method comprises providing a contact record for each of a plurality of users, the contact record for each user comprising a plurality of fields, wherein at least one of the contact records for a first user has a first user identifier in a first field having an associated first communications method. A subsequent step may comprise receiving a communication from a user by means of a second, different communications method, the communication having an associated second user identifier corresponding to at least part of the first user identifier. A subsequent step may comprise identifying the contact record for the first user based on the second user identifier. A subsequent step may comprise updating the identified contact record so that at least one of the fields comprises new information from the second user identifier.